Activation of anthracycline anti-cancer agents by nanoparticle therapy

Suzanne CuttsDr Suzanne Cutts

ARC Future Fellow, Faculty of Science, Technology and Engineering

View profile, publications and contact details

Dr Suzanne Cutts

Dr Suzanne Cutts discusses her research on using anthracyclines to kill cancer cells more potently.

blog comments powered by Disqus

Print version Close